Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948386 · ClinicalTrials.gov registry record · Phase 4
3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT03948386 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 159 participants.
The verdict
NCT03948386, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
Spinal anesthesia is commonly utilized for hip replacement surgery. Different medications used for spinal anesthesia work for different lengths of time. This study will compare three different spinal anesthesia medications in patients having hip replacement surgery to see if patients are able to get out of bed and walk earlier after surgery with one medication versus the others.
Interventions
- DRUG isobaric bupivacaine
- DRUG hyperbaric bupivacaine
- DRUG isobaric mepivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2019-11-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03948386
The ClinicalTrials.gov registry entry for NCT03948386 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which isobaric bupivacaine is the first listed.
NCT03948386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03948386 about?
NCT03948386 is a clinical study titled "3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty". Spinal anesthesia is commonly utilized for hip replacement surgery. Different medications used for spinal anesthesia work for different lengths of time. This study will compare three different spinal anesthesia medications in patients having hip replacement surgery to see if patients are able to get...
What is the current status of trial NCT03948386?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 2019-05-13. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT03948386?
The interventions under investigation include: isobaric bupivacaine (DRUG), hyperbaric bupivacaine (DRUG), isobaric mepivacaine (DRUG).
Who is sponsoring clinical trial NCT03948386?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.